
Bitnomial launches Injective futures in US, with eyes on ETF eligibility
Chicago-based crypto exchange Bitnomial has launched monthly futures contracts tied to Injective, marking the first US-regulated derivatives product for the Web3 financial ecosystem’s native token. According to Wednesday’s announcement shared with Cointelegraph, the contracts settle in $INJ ($INJ) with monthly expiries, allowing traders to gain price exposure without holding the underlying asset, and can be margined in crypto or US dollars through Bitnomial’s clearinghouse. The listing also starts a six-month track record that could support a spot exchange-traded fund under US Securities and Exchange Commission (SEC) listing rules. In July, Canary Capital filed for a staked $INJ ETF, with Cboe…








